Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF) (PreCONDITION)

This study has been completed.
Sponsor:
Collaborator:
Momentum Research, Inc.
Information provided by:
Nile Therapeutics
ClinicalTrials.gov Identifier:
NCT00699712
First received: June 10, 2008
Last updated: March 23, 2009
Last verified: March 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2008
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)